Neogenomics (NEO) Cash from Operations (2010 - 2026)

Neogenomics has reported Cash from Operations for 17 years, with the latest figure at 8137000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations rose 67.87% year-over-year to 8137000.0; the trailing twelve-month figure through Mar 2026 stood at 22420000.0 (up 194.57% YoY), and the FY2025 full-year result was 5230000.0, down 25.53% from the prior year.
• Cash from Operations for Q1 2026 stood at 8137000.0, down from 1343000.0 in the prior quarter.
• The five-year high for Cash from Operations was 20330000.0 in Q2 2025, with the low at 29040000.0 in Q1 2022.
• Historically, Cash from Operations has averaged 3754705.88 across 5 years, with a median of 3685000.0 in 2022.
• Annual changes were most pronounced in 2022 — Cash from Operations sank 1414.03% — and 2024, when it soared 997.42%.
• Neogenomics' Cash from Operations stood at 3685000.0 in 2022, then jumped by 582.61% to 17784000.0 in 2023, then sank by 44.89% to 9800000.0 in 2024, then tumbled by 86.3% to 1343000.0 in 2025, then sank by 705.88% to 8137000.0 in 2026.
• The last three Cash from Operations figures came in at 8137000.0 (Q1 2026), 1343000.0 (Q4 2025), and 8884000.0 (Q3 2025), per Business Quant data.